Recently Farrell et al., have reported that endogenous inhibitors of PP2A, SET (also known as I2PP2A) and CIP2A were overexpressed in human pancreatic cancer and contributed to decreased PP2A activity as well as overexpression and stabilization of the oncoprotein c-MYC [52]. The gene discussed is PTPA; the disease is pancreatic neoplasm.